Gullimex attracts investor Holland Capital for further growth
Borne / Amsterdam, 10th of March 2025 – Investment firm Holland Capital is investing in Gullimex, a strong player in measurement, quality, and control solutions within the food and medical sectors. Holland Capital’s investment provides Gullimex the opportunity to realize its growth ambitions.
Growing quality standards
The importance of food safety, patient safety, and hygiene continues to grow in a market characterized by increasingly stringent regulations and rising expectations regarding quality and efficiency. Gullimex supports businesses and institutions in navigating this dynamic and demanding environment, optimizing their processes through its role as an advisor, premium brand supplier, and service partner.
Gullimex ensures consistent quality measurements, optimal hygiene, and safe production within mission-critical processes. The company achieves this through an integrated combination of hardware, software, and services, providing customers with solutions that directly address the specific needs and challenges of the food and medical sectors.
Investment for growth
Gullimex aims to become the leading European provider of measurement, quality, and control solutions, leveraging data to create value for the food and medical industries. With Holland Capital’s investment, the company can achieve its growth ambitions both organically and through strategic acquisitions.
Maarten Snijders, Investment Director AgriFood-Tech at Holland Capital, said: “We are proud to support Gullimex in achieving its ambitions. As an investor with years of experience in Tech, AgriFood, and Healthcare, we aim to contribute to Gullimex’s international growth and its mission to create even more value for all its partners.”
Lucien Kwakkel, CEO of Gullimex, added: “We value Holland Capital as a strategic partner that not only invests in our growth but also actively supports us with expertise, experience, a strong network, and a hands-on mentality. Thanks to their experience and vision, we can further strengthen our position in key markets and accelerate our ambitions both nationally and internationally.”
About Gullimex
Founded in 1981, Gullimex supports a large customer base within the food and medical sectors with measurement and data recording solutions. The team of 60+ experts is active in the fields of food safety, patient safety, and hygiene. Gullimex has offices in the Netherlands, Belgium, and Germany.
About Holland Capital
For over 40 years, Holland Capital has been responsibly and successfully investing in promising Dutch and German SMEs with growth ambitions. The team understands entrepreneurship and strives for an open, sustainable, and professional relationship with the management teams of the companies in which it invests, with the common goal of achieving growth. Holland Capital has offices in Amsterdam and Düsseldorf. With its specialized sector teams, the firm focuses on Healthcare, Technology, and AgriFood-Tech. It understands the dynamics and opportunities within these sectors and has an extensive network.
Our portfolio company Sirius Medical is partnering with Mammotome
Our portfolio company Sirius Medical, the innovator of Surgical Marker Navigation and Mammotome, a globally recognized leader in breast care, are proud to announce an exclusive distribution agreement for the United States and Germany.
Ons portfoliobedrijf Sirius Medical en Mammotome gaan samenwerking aan
Ons portfoliobedrijf Sirius Medical, pionier op het gebied van Surgical Marker Navigation, en Mammotome, een wereldwijd erkende leider in borstkankerzorg, zijn trots om een exclusieve distributieovereenkomst voor de Verenigde Staten en Duitsland aan te kondigen.
Our portfolio company Sirius Medical secures growth funding from new and existing investors
Our portfolio company Sirius Medical, a leading medtech company and market leader in oncological surgical marker navigation, has raised €10 million in funding on World Cancer Day.
Sirius Medical haalt groeifinanciering op bij nieuwe en bestaande investeerders
Ons portfolio bedrijf Sirius Medical, een toonaangevend medisch-technologiebedrijf en marktleider in onco-chirurgische marker-navigatie, heeft een financiering van € 10 miljoen euro opgehaald op Wereldkankerdag.
Beyonder is de nieuwe naam van House of Clouds
House of Clouds heeft een belangrijke stap gezet in haar groeiambities en gaat vanaf vandaag verder onder de naam Beyonder. Tijdens een feestelijke bijeenkomst in het Eindhovense Natlab onthulde CEO Sander Dekker de nieuwe naam en merkidentiteit, samen met alle collega’s.
Beyonder – The new name for House of Clouds
House of Clouds has taken a significant step in its growth journey by rebranding to Beyonder. During a celebratory event at Eindhoven’s Natlab, CEO Sander Dekker unveiled the company’s new name and brand identity alongside the entire team.
Amsterdam
Krijn Taconiskade 426
1087 HW Amsterdam
+31 (0) 20 3119411
Düsseldorf
Königsallee 42
40212 Düsseldorf
+49 (0) 211 96290120
Contact
info@hollandcapital.nl

